Top

Published in:

Open Access 01-12-2021 | Gout | Systematic review update

Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic review

Authors: Can Wang, Xufei Luo, Maichao Li, Lingling Cui, Xinde Li, Lin Han, Xuefeng Wang, Wei Ren, Yuwei He, Wenyan Sun, Changgui Li, Yaolong Chen, Zhen Liu

Published in: Systematic Reviews | Issue 1/2021

Abstract

Background

The Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist was used to assess the reporting quality of 2009–2019 clinical practice guidelines (CPGs) regarding gout and hyperuricemia, aimed to improve the reporting quality of future guidelines.

Methods

We searched PubMed, the Chinese Biomedical Literature database, the Wanfang Database, and the China National Knowledge Infrastructure from January 2009 to June 2019 for guidelines regarding gout and hyperuricemia. We also searched the websites of guideline development organizations (the Guidelines International Network, the National Institute for Health and Clinical Excellence, the American College of Rheumatology, and the European League Against Rheumatism (EULAR)). Furthermore, supplementary guidelines reported in included articles were systematically searched, as well as Google Scholar.

Results

Seventeen guidelines were included, of which one was in Chinese and 16 were in English. The mean reporting rate of the 35 items specified was 14.9 (42.5%); only five CPGs (29.4%) had a reporting rate >50%. Of the 35 items, three were very frequently reported. The reporting proportion of the seven domains (basic information, background, evidence, recommendations, review and quality assurance, funding and declaration and management of interests, and other information) were 64.7%, 36.8%, 50.6%, 42.9%, 8.82%, 33.8%, and 31.4%, respectively.

Conclusion

The reporting quality of the present guidelines for gout and hyperuricemia is relatively poor. We suggest that the RIGHT reporting checklist should be used by CPG developers to ensure higher reporting quality of future guidelines.

Available only for authorised users

Xia Y, Wu Q, Wang H, Zhang S, Jiang Y, Gong T, et al. Global, regional and national burden of gout, 1990-2017: a systematic analysis of the Global Burden of Disease Study. Rheumatology (Oxford). 2020;59(7):1529–38. https://doi.org/10.1093/rheumatology/kez476.

Rai SK, Burns LC, de Vera MA, Haji A, Giustini D, Choi HK. The economic burden of gout: a systematic review. Semin Arthritis Rheum. 2015;45(1):75–80. https://doi.org/10.1016/j.semarthrit.2015.02.004.CrossRefPubMed

Shiozawa A, Szabo SM, Bolzani A, Cheung A, Choi HK. Serum uric acid and the risk of incident and recurrent gout: a systematic review. J Rheumatol. 2017;44(3):388–96. https://doi.org/10.3899/jrheum.160452.CrossRefPubMed

MacFarlane LA, Kim SC. Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin North Am. 2014;40(4):581–604. https://doi.org/10.1016/j.rdc.2014.07.002.CrossRefPubMedPubMedCentral

Wang D, Yu Y, Chen Y, Yang N, Zhang H, Wang C, et al. Assessing the quality of global clinical practice guidelines on gout using AGREE II instrument. J Clin Rheumatol. 2020;26(2):54–9. https://doi.org/10.1097/RHU.0000000000000921.

Yu Y, et al. Recommendations in clinical practice guidelines on gout: systematic review and consistency analysis. Clin Exp Rheumatol. 2020.

Ughi N, Prevete I, Ramonda R, Cavagna L, Filippou G, Manara M, et al. The Italian Society of Rheumatology clinical practice guidelines for the diagnosis and management of gout. Reumatismo. 2019;71(S1):50–79. https://doi.org/10.4081/reumatismo.2019.1176.

Li Q, Li X, Wang J, Liu H, Kwong JS, Chen H, et al. Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open. 2019;9(8):e026677. https://doi.org/10.1136/bmjopen-2018-026677.

Yang N, Yu Y, Zhang A, Estill J, Wang X, Zheng M, et al. Reporting, presentation and wording of recommendations in clinical practice guideline for gout: a systematic analysis. BMJ Open. 2019;9(1):e024315. https://doi.org/10.1136/bmjopen-2018-024315.

10.

Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical practice guidelines we can trust. Washington, DC: National Academies Press; 2011.

11.

Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet. 2000;355(9198):103–6. https://doi.org/10.1016/S0140-6736(99)02171-6.CrossRefPubMed

12.

Chen Y, Yang K, Marušic A, Qaseem A, Meerpohl JJ, Flottorp S, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med. 2017;166(2):128–32. https://doi.org/10.7326/M16-1565.

13.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839–42. https://doi.org/10.1503/cmaj.090449.

14.

Chen Y, Yang K, Marušić A, Qaseem A, Meerpohl JJ, Flottorp S, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Z Evid Fortbild Qual Gesundhwes. 2017;127-128:3–10. https://doi.org/10.1016/j.zefq.2017.10.008.

15.

Xiao Y, Jiang L, Tong Y, Luo X, He J, Liu L, et al. Evaluation of the quality of guidelines for assisted reproductive technology using the RIGHT checklist: a cross-sectional study. Eur J Obstet Gynecol Reprod Biol. 2019;241:42–8. https://doi.org/10.1016/j.ejogrb.2019.07.039.

16.

Wang D, et al. Assessing the quality of global clinical practice guidelines on gout using AGREE II instrument. J Clin Rheumatol. 2018.

17.

Collaboration, A. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12(1):18–23.CrossRef

18.

Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 16. Evaluation. Health Res Policy Syst. 2006;4(1):28. https://doi.org/10.1186/1478-4505-4-28.CrossRefPubMed

19.

Yao X, Ma J, Wang Q, Kanters D, Ali MU, Florez ID. A comparison of AGREE and RIGHT: which clinical practice guideline reporting checklist should be followed by guideline developers? J Gen Intern Med. 2020;35(3):894–8. https://doi.org/10.1007/s11606-019-05508-3.CrossRefPubMed

20.

Johnston A, Kelly SE, Hsieh SC, Skidmore B, Wells GA. Systematic reviews of clinical practice guidelines: a methodological guide. J Clin Epidemiol. 2019;108:64–76. https://doi.org/10.1016/j.jclinepi.2018.11.030.CrossRefPubMed

21.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020;79(1):31–8. https://doi.org/10.1136/annrheumdis-2019-215315.

22.

Yu KH, Chen DY, Chen JH, Chen SY, Chen SM, Cheng TT, et al. Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan. Int J Rheum Dis. 2018;21(4):772–87. https://doi.org/10.1111/1756-185X.13266.

23.

Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, et al. The British Society for Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2017;56(7):1246. https://doi.org/10.1093/rheumatology/kex250.

24.

Qaseem A, McLean RM, Starkey M, Forciea MA, for the Clinical Guidelines Committee of the American College of Physicians. Diagnosis of acute gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(1):52–7. https://doi.org/10.7326/M16-0569.CrossRefPubMed

25.

Qaseem A, Harris RP, Forciea MA, for the Clinical Guidelines Committee of the American College of Physicians. Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(1):58–68. https://doi.org/10.7326/M16-0570.CrossRefPubMed

26.

Chinese Rheumatology A. China gout clinical practice guideline. Zhonghua Nei Ke Za Zhi. 2016;55(11):892–9.

27.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42. https://doi.org/10.1136/annrheumdis-2016-209707.

28.

Kiltz U, Smolen J, Bardin T, Cohen Solal A, Dalbeth N, Doherty M, et al. Treat-to-target (T2T) recommendations for gout. Ann Rheum Dis. 2017;76(4):632–8. https://doi.org/10.1136/annrheumdis-2016-209467.

29.

Graf SW, Whittle SL, Wechalekar MD, Moi JHY, Barrett C, Hill CL, et al. Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3e initiative. Int J Rheum Dis. 2015;18(3):341–51. https://doi.org/10.1111/1756-185X.12557.

30.

Neogi T, Jansen TLTA, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789–98. https://doi.org/10.1136/annrheumdis-2015-208237.

31.

Araujo F, et al. Portuguese recommendations for the diagnosis and management of gout. Acta Reumatol Port. 2014;39(2):158–71.PubMed

32.

Spanish Society of Rheumatology. Clinical practice guidelines for management of gout. 2013. Available from: https://www.guidelinecentral.com/summaries/clinical-practice-guidelines-for-management-of-gout/#section-society.

33.

Sivera F, Andrés M, Carmona L, Kydd ASR, Moi J, Seth R, et al. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis. 2014;73(2):328–35. https://doi.org/10.1136/annrheumdis-2013-203325.

34.

Manara M, Bortoluzzi A, Favero M, Prevete I, Scirè CA, Bianchi G, et al. Italian Society of Rheumatology recommendations for the management of gout. Reumatismo. 2013;65(1):4–21. https://doi.org/10.4081/reumatismo.2013.4.

35.

The University of Texas at Austin, S.o.N., Family Nurse Practitioner Program, , Management of chronic gout in adults. Available from: https://www.ahrq.gov/gam/index.html., 2012.

36.

Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken), 2012. 2012;64(10):1431–46. https://doi.org/10.1002/acr.21772.

37.

Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, et al. American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken), 2012. 2012;64(10):1447–61. https://doi.org/10.1002/acr.21773.

38.

Yamanaka H, Japanese Society G. of, and M. Nucleic Acid, Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids. 2011;30(12):1018–29. https://doi.org/10.1080/15257770.2011.596496.CrossRefPubMed

39.

The University of Texas at Austin, School of Nursing, Family Nurse Practitioner Program, Management of initial gout in adults. 2009. [cited September 12 2018]. Available from: https://www.ahrq.gov/gam/index.html.

Title: Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic review
Authors: Can Wang
Xufei Luo
Maichao Li
Lingling Cui
Xinde Li
Lin Han
Xuefeng Wang
Wei Ren
Yuwei He
Wenyan Sun
Changgui Li
Yaolong Chen
Zhen Liu
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Gout
Published in: Systematic Reviews / Issue 1/2021
Electronic ISSN: 2046-4053
DOI: https://doi.org/10.1186/s13643-021-01645-1

At a glance: The STEP trials

Springer Medicine

Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic review

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Integrated Risk Information System (IRIS) response to “Assessing risk of bias in human environmental epidemiology studies using three tools: different conclusions from different tools”

P value and Bayesian analysis in randomized-controlled trials in child health research published over 10 years, 2007 to 2017: a methodological review protocol

Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis

Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review

The impacts of health systems financing fragmentation in low- and middle-income countries: a systematic review protocol

The use of theories, frameworks, or models in knowledge translation studies in healthcare settings in China: a scoping review protocol